Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People With Non-Neoplastic Hematologic Disorders

NCT04398628 is registered in ClinicalTrials.gov with American Thrombosis and Hemostasis Network as lead sponsor.

NCT NCT04398628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04398628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATHN Transcends: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment in People With Non-Neoplastic Hematologic Disorders
Lead sponsor
American Thrombosis and Hemostasis Network
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2020
Completion date
December 31, 2035
Enrollment
3,000 (estimated)
Sites
76

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding disorder, connective tissue disorder, factor ix deficiency, factor viii deficiency, hematologic disorder, hemophilia, platelet disorder, rare bleeding disorder, sickle cell disease, thalassemia, thrombophilia, thrombosis, von willebrand diseases